Suppr超能文献

在难治性心源性休克合并心脏骤停并经静脉-动脉体外膜肺氧合复苏的猪模型中血管加压素与去甲肾上腺素的比较

Comparison of Vasopressin versus Norepinephrine in a Pig Model of Refractory Cardiogenic Shock Complicated by Cardiac Arrest and Resuscitated with Veno-arterial ECMO.

作者信息

Klein Thomas, Grandmougin Daniel, Liu Yihua, Orlowski Sophie, Albuisson Eliane, Tran N'Guyen, Levy Bruno

机构信息

CHRU Nancy, Service de Réanimation Médicale Brabois, Pôle Cardio-Médico-Chirurgical Médicale, Hôpital Brabois, Vandoeuvre les Nancy, France.

INSERM U 1116, Groupe Choc, Equipe 2, Faculté de Médecine, Vandoeuvre les Nancy, France.

出版信息

Shock. 2021 Sep 1;56(3):473-478. doi: 10.1097/SHK.0000000000001747.

Abstract

BACKGROUND

The choice of the best vasopressor after ExtraCorporeal Membrane Oxygenation (ECMO) implantation after cardiac arrest is not well defined. Circulatory flow recovery with ECMO is associated with vasoplegia and vasopressor need. The present study aimed to compare the effects of norepinephrine and vasopressin in the first 6 h after ECMO initiation.

METHODS

Cardiac arrest was induced in 20 pigs by coronary surgical ligature and veno-arterial-ECMO was started after a 30-min period of cardio-pulmonary resuscitation. Pigs were randomized into two groups, arginine vasopressin (AVP) or norepinephrine (NE), with the drugs titrated to maintain a mean arterial pressure (MAP) at 65 mm Hg. Macrocirculatory and metabolic parameters were assessed by lactate clearance. Microcirculatory parameters were assessed by sublingual microcirculation with Sidestream Dark Field imaging and peripheral Near InfraRed Spectroscopy. Pulmonary edema was evaluated by measuring lung wet/dry weight ratio.

RESULTS

No difference was found between groups regarding ECMO flow and MAP. Fluid resuscitation volume was higher in the NE group (14,000 [11,250-15,250] mL vs. 3,500 [1,750-4,000] mL in the AVP group, P < 0.05). Lung wet/dry weight ratio was higher in the Norepinephrine group. Lactate clearance between H0 and H6 was higher in the AVP group (47.84 [13.42-82.73]% vs. the NE group 25.66 [-7.31 to 35.34)% vs. P < 0.05). No significant difference was observed for sublingual microcirculation values. Baseline tissue oxygen saturation was comparable and higher at both H3 and H6 in the Vasopressin group comparatively to the Norepinephrine group (P < 0.05). Renal and liver function evolution also remained similar in the two groups throughout the study.

CONCLUSIONS

AVP administration in refractory cardiac arrest resuscitated by veno-arterial-ECMO is associated with a faster lactate clearance, less fluid resuscitation, and less pulmonary edema when compared with NE for similar global and regional hemodynamic effects.

摘要

背景

心脏骤停后体外膜肺氧合(ECMO)植入后最佳血管加压药的选择尚不明确。ECMO使循环血流恢复与血管麻痹及血管加压药需求有关。本研究旨在比较ECMO启动后最初6小时内去甲肾上腺素和血管加压素的效果。

方法

通过冠状动脉手术结扎诱导20头猪发生心脏骤停,并在30分钟心肺复苏后开始静脉-动脉-ECMO。将猪随机分为两组,精氨酸血管加压素(AVP)组或去甲肾上腺素(NE)组,滴定药物以维持平均动脉压(MAP)在65 mmHg。通过乳酸清除率评估大循环和代谢参数。通过侧流暗视野成像和外周近红外光谱法对舌下微循环进行评估来评估微循环参数。通过测量肺湿/干重比评估肺水肿。

结果

两组在ECMO流量和MAP方面未发现差异。NE组的液体复苏量更高(14,000 [11,250 - 15,250] mL,而AVP组为3,500 [1,750 - 4,000] mL,P<0.05)。去甲肾上腺素组的肺湿/干重比更高。AVP组在H0至H6之间的乳酸清除率更高(47.84 [13.42 - 82.73]%,而NE组为25.66 [-7.31至35.34]%,P<0.05)。舌下微循环值未观察到显著差异。与去甲肾上腺素组相比,血管加压素组在H3和H6时的基线组织氧饱和度相当且更高(P<0.05)。在整个研究过程中,两组的肾功能和肝功能变化也保持相似。

结论

与NE相比,在静脉-动脉-ECMO复苏的难治性心脏骤停中给予AVP,在产生相似的整体和局部血流动力学效应时,乳酸清除更快,液体复苏更少,肺水肿更少。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验